Kristen Stants is Chief People Officer of Magenta Therapeutics, Inc.. Currently has a direct ownership of 20,264 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2022, when has been sold 3,000 shares (Common Stock) at a price of $0.94 per share, resulting in proceeds of $2,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.3K
0% 3M change
0% 12M change
Total Value Held $0

Kristen Stants Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2022
BUY
Grant, award, or other acquisition
$2,820 $0.94 p/Share
3,000 Added 12.9%
20,264 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
$2,970 $0.99 p/Share
3,000 Added 14.8%
17,264 Common Stock
Sep 16 2021
SELL
Open market or private sale
$38,603 $6.73 p/Share
5,736 Reduced 28.68%
14,264 Common Stock
Sep 14 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock
KS

Kristen Stants

Chief People Officer
Cambridge, MA

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Track Activities on MGTA